Companies / DEBN
DEBN
Company
DEBN is a medical device that delivers an effective antibiotic combination directly to the prostate during a biopsy procedure
DEBN has 1 investor on file, among them Alfabeat. Its site was last checked 6 Nov 2026: site answers.
Investors
1 investor on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital |
More from Alfabeat
12 companies on its checked portfolioIts portfolio leans to AI & Machine Learning (14%), Enterprise Software (14%), E-commerce & Marketplaces (9%).
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get DEBN and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Alfabeat adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/debn.eu/investors
# also
GET /v1/companies/debn.eu
GET /v1/companies/debn.eu/news